Because ibuprofen protects from septic lung injury, we studied the effect of ibuprofen in oxidant lung injury from phosgene. Lungs from rabbits exposed to 2,000 ppm-min phosgene were perfused with Krebs-Henseleit buffer at 50 ml/min for 60 min. Phosgene caused no increase in lung generation of cyclooxygenase metabolites and no elevation in pulmonary arterial pressure, but markedly increased transvascular fluid flux (delta W = 31 +/-5 phosgene vs. 8 +/-1 g unexposed, P less than 0.001), permeability to albumin (125I-HSA) lung leak index 0.274 +/-0.035 phosgene vs. 0.019 +/-0.001 unexposed, P less than 0.01; 125I-HSA lavage leak index 0.352 +/-0.073 phosgene vs. 0.008 +/-0.001 unexposed, P less than 0.01), and lung malondialdehyde (50 +/-7 phosgene vs. 24 +/-0.7 mumol/g dry lung unexposed, P less than 0.01). Ibuprofen protected lungs from phosgene (delta W = 10 +/-2 g; lung leak index 0.095 +/-0.013; lavage leak index 0.052 +/-0.013; and malondialdehyde 16 +/-3 mumol/g dry lung, P less than 0.01). Because iron-treated ibuprofen failed to protect, we studied the effect of ibuprofen in several iron-mediated reactions in vitro. Ibuprofen attenuated generation of .OH by a Fenton reaction and peroxidation of arachidonic acid by FeCl3 and ascorbate. Ibuprofen also formed iron chelates that lack the free coordination site required for iron […] 
Introduction
Ibuprofen is one of the most useful nonsteroidal anti-inflammatory agents available to humans. Originally intended as a therapy for arthritis, it is now available as a nonprescription antipyretic and analgesic. Recently, ibuprofen has been shown to ameliorate acute lung injury in animals induced by sepsis (1, 2) , the pesticide paraquat (3) , burn injury (4), smoke inhalation (5) , and thrombin (6) . Ibuprofen also attenuates experimental endotoxin shock (7, 8) and is undergoing trial as a treatment for septic shock in humans. Because many of these entities are in part oxidant-mediated illnesses, we evaluated ibuprofen as a therapy for toxic oxidant gas inhalation. We chose the oxidant phosgene as a model of inhalational injury because it is extremely reactive and commercially important and characteristically produces acute noncardiogenic pulmonary edema as its most serious health effect in human beings (9) . We report that ibuprofen markedly attenuates lung injury from phosgene. In this model ibuprofen appears to act as an iron chelator, possibly preventing iron-mediated oxidant generation and lipid peroxidation caused by phosgene.
Methods

Lung perfusion experiments
In initial studies we determined that exposure to 200 ppm phosgene for 10 min (2,000 ppm-min) consistently caused profound lung injury, characterized by increased transvascular fluid flux and wet/dry lung weight ratios (10) . This dose of phosgene was used for all experiments. We used transvascular fluid flux during lung perfusion and lung wet/ dry weight ratios to assess phosgene lung injury (10) (11) (12) (13) . Microvascular permeability to macromolecules was studied by measuring the flux of '251I-albumin from the vascular space into lung water and lavage fluid. To assess injury biochemically, we measured perfusate and bronchoalveolar lavage levels of cyclooxygenase mediators to determine whether phosgene activated this pathway ofarachidonate metabolism, and lung content of malondialdehyde to determine if phosgene caused peroxidation of lung lipids.
PHOSGENE EXPOSURES
We exposed rabbits to phosgene using a specially constructed facility.
Phosgene was prepared by Matheson Gas Products, Inc., New York, and stored in 3-qt. cylinders at a concentration of200 ppm in ultrapure air. Stability of the mixture was verified over 3 wk and periodically thereafter using the method of Noweir and Pfitzer (14). Cylinder pressure (1,800 psi) was reduced to a delivery pressure of 10 psi with a model B15 regulator coupled to a model 206 rotameter (both from Matheson Gas Products, Inc.) for adjustment of flows from 0 to 25 liter/min. Both regulator and rotameter were fitted with corrosion-resistant valves. The cylinder and valve assembly were enclosed under a single high-velocity (1,200 liters/min) laboratory exhaust hood to contain any accidental leakage of phosgene. Animal exposures were performed in a sealed plexiglass box placed inside a second smaller laboratory exhaust hood. The plexiglass box was connected to the valve and rotameter assembly by seamless 1/3 in. stainless steel tubing. The effluent of the box and exposure hood was exhausted into a scrubber (Mystaire HS-7, Heat Systems-Ultrasonics, Inc., Farmingdale, NY). This scrubber detoxifies phosgene by continuous exposure of effluent to a 0.2% aqueous solution of potassium hydroxide (pH = 9).
This detoxification is based on the principle that phosgene reacts rapidly with water to form HCI and CO2. HCl is subsequently neutralized by the caustic in the mist. Investigators wore positive pressure selfcontained breathing devices while in the exposure facility (ISI Ranger SCBA Apparatus, Direct Safety Co., Phoenix, AZ) and carried Monotox personal safety alarms (MDA Scientific, Inc., Lincolnshire, IL) which provide audio alert of atmospheric phosgene concentrations greater than the threshold limit value of 0.1 ppm.
Male New Zealand White rabbits (Myrtle Farms, Nashville, TN) weighing 2.5-3.0 kg were maintained on laboratory diet (Carnation Rabbit Formula 18) and water ad libitum. On the day of the experiment, a protective water-based ointment was instilled into the rabbits' eyes to prevent conjunctival and corneal irritation. Rabbits were sealed into the plexiglass exposure box and the phosgene mixture was delivered into the box at 5 liter/min. The exposure dose of phosgene was adjusted by increasing the duration of exposure to the fixed (200 ppm) concentration of gas. Exposure dose was expressed as the concentration X time product (ppm-min) (15) . At the end of timed exposures, phosgene was flushed from the box for 10 min by compressed air at a flow of 25 liter/min before the animal was removed. Anesthesia was not required, as animals appeared to experience little distress during exposures. Use of rabbits in these experiments was approved by the Animal Welfare and Use Committee.
LUNG PERFUSION TECHNIQUES
Rabbits were anesthetized with pentobarbital sodium (25 mg/kg) and given 3,000 U of heparin by ear vein. The chest was opened, and the animal was killed by rapid exsanguination from the left ventricle. Right and left parasternal incisions were made along the costal cartilages to remove the sternum and open the chest widely. Stainless steel cannulas were secured in the left atrium and pulmonary artery with umbilical tape. The ligature around the pulmonary artery was also passed around the aorta, preventing loss of perfusate into the systemic circulation. The pulmonary circulation was washed free of blood with -500 ml of perfusate before recirculating flow was established at 50 ml/min. The perfusate medium was protein-free Krebs-Henseleit buffer (16) maintained at a temperature of 37-380C and pH of 7.35-7.40.
The lungs were ventilated with 5% CO2 in air through a tracheostomy using. an animal respirator (Harvard Apparatus Co., Inc., S. Natick, MA) delivering a tidal volume of 7 ml/kg at 18 breaths/min with a 2 cm H20 positive end-expiratory pressure. Lungs were perfused through a 250-ml circuit which included a perfusate reservoir, roller perfusion pump (Sans, Ann Arbor, MI), filter (Swank transfusion filter, Extracorporeal Medical Specialities, King of Prussia, PA), and a heat exchanger, connected by Tygon tubing. The reservoir collecting perfusate from the left atrium was suspended from a force displacement transducer (model FT1OD, Grass Instrument Co., Quincy, MA) so that loss of reservoir weight from transvascular fluid flux could be continuously measured. The perfusate reservoir was placed below the lower most portion of the lung to keep left atrial pressure at zero.
Pulmonary arterial and left atrial pressures were monitored using pressure transducers (model P23ID, Gould-Statham Instruments, Inc., Hato Rey, Puerto Rico) connected to the inflow circulation, outflow circulation, and tracheal cannula. Pressure and force transducer measurements were recorded on a four-channel recorder (model 2400S, Gould, Inc., Recording Systems Div., Cleveland, OH). At the end of perfusion, lungs were dissected free from the thorax, and one lung was snap-frozen immediately in liquid N2 and stored at -70°C until later biochemical analysis. The wet/dry weight ratio of the remaining lung was determined by recording wet weight and drying the lung in a vacuum oven at 85°C for 72 h, or until dry lung weight was stable.
EXPERIMENTAL DESIGN
Lungs perfused immediately after exposure. To determine if pretreatment with ibuprofen could attenuate lung injury from phosgene, rabbits were pretreated with ibuprofen, exposed to phosgene, and studied immediately after exposure. Injury was assessed by transvascular fluid flux during lung perfusion. Lung perfusion was generally started 60 min after the beginning ofphosgene exposure. Lungs were perfused for 60 min, during which time samples ofeffluent perfusate were collected at 0, 20, 40, and 60 min and frozen for later measurement of thromboxane B2 (TXB2), the metabolite ofthe vasoconstrictor thromboxane A2, and 6-keto-PGFI., the metabolite of prostacyclin. At the end of lung perfusion, wet/dry weight ratios were determined on one lung. The remaining lung was snap frozen for measurement of malondialdehyde. Three groups ofrabbits were studied. The first group was sham exposed to air rather than phosgene. The second group was exposed to phosgene, but not pretreated. The third group was pretreated with ibuprofen 25 mg/kg given intravenously 30 min before phosgene exposure. After lung perfusion was begun, treatment was continued by adding 50 ug/ml of ibuprofen to the perfusate. This dose of ibuprofen is similar to that previously reported to attenuate thrombin-induced lung injury (6) . In separate experiments, we measured the concentration of TXB2 and 6-keto-PGF1,, in the bronchoalveolar fluid from sham-exposed animals (n = 3) and phosgene exposed animals (n = 3). The lungs of these animals were perfused for 60 min and then bronchoalveolar fluid was obtained.
Lung injury studied 4 h after exposure. To determine if ibuprofen could attenuate lung injury when given after exposure, rabbits were exposed to phosgene, treated immediately afterward with ibuprofen, and then studied 4 h later. In addition, other rabbits were pretreated with the food additive antioxidant butylated hydroxyanisole (BHA)' to determine if oxidant injury from phosgene could be ameliorated by antioxidant therapy (17, 18) . Injury was assessed by transvascular fluid flux and lung wet/dry weight ratios. This protocol was used to mimic the usual situation occurring after an industrial accident, when phosgene characteristically produces symptomatic lung edema 4-8 h after exposure (9) .
Four groups of rabbits were studied: unexposed controls, untreated phosgene controls, rabbits pretreated with BHA before phosgene exposure, and rabbits exposed to phosgene and treated afterward with ibuprofen. Rabbits treated with BHA were injected with 100 mg/kg intraperitoneally for 3 d before phosgene exposure. This dose of BHA is similar to that previously shown to prevent oxidant injury in rabbit lungs (17, 18) . Rabbits treated with ibuprofen were injected with 12.5 mg/kg intravenously after phosgene exposure and 12.5 mg/kg intraperitoneally 2 and 4 h later. Ibuprofen was first injected 10 min after rabbits were removed from the exposure chamber to approximate emergency treatment which might begin at the site of a workplace accident. The ibuprofen treatment protocol was similar to that previously used to prevent septic (1, 2) and thermal (4) Five groups were studied: unexposed controls; untreated phosgene controls, phosgene-exposed rabbits pretreated with ibuprofen, phosgene-exposed animals pretreated with ibuprofen that had been iron saturated, and phosgene-exposed animals pretreated with the same amount of iron used to saturate ibuprofen. Ibuprofen was given intravenously (25 mg/kg) 30 min before exposure and 50 Ag/ml was added to the perfusate at the start of lung perfusion. Ibuprofen was irontreated by mixing it in saline with sufficient FeCI3 to provide a 6:1 molar ratio of ibuprofen to iron (25 mg/kg ibuprofen mixed with 5.5 mg/kg of FeCl3). This ratio was chosen because we hypothesized that the propionic acid group of ibuprofen could bind one of iron's six coordination sites (19) . Rabbits treated with iron alone were given 5.5 mg/kg of FeCI3 in 2 ml normal saline (pH adjusted to 7.0) by slow intravenous injection before phosgene exposure, and 2.25 mg/kg was added to the recirculating buffer during lung perfusion.
MEASUREMENT OF CYCLOOXYGENASE METABOLITES TXB2 and 6-keto-PGF1,a were measured by radioimmunoassay as described previously (20) . The radioimmunoassays used are sensitive to 20 pg/ml and employ dextran-coated charcoal as the separation technique. Cross-reactivity of all rabbit antiserums was evaluated with the following heterologous ligands: PGF2a, PGE1, PGE2, 6-keto-PGF1,, and thromboxane B2. Antiserum cross-reactivity was < 1% with all heterologous ligands except with 6-keto-PGFI., which has a 4.5% cross-reactivity with PGF2a, 2.9% with PGE1, and 2.3% with PGE2 (20) .
MEASUREMENT OF LUNG MALONDIALDEHYDE
Malondialdehyde was determined by the method of Buege and Aust (21) . Weighed 250-mg portions of defrosted lungs were homogenized on ice with 2 ml of 1.15% KC1 and mixed with 4 ml of the reagent (0.375% thiobarbituric acid and 15% trichloroacetic acid in 0.25 N HCI, to which 0.01% butylated hydroxytoluene was added just before use). After incubation at 100°C for 20 min, the absorbance of the supernatant was measured at 532 nm. An extinction coefficient of 1.56 X 105 M' cm-' and lung wet/dry weight ratios were used to determine micromoles of malondialdehyde per gram of dry lung.
In vitro experiments IRON-MEDIATED -OH GENERATION
The ability of ibuprofen to suppress iron-mediated hydroxyl radical (*OH) generation from hydrogen peroxide (H202) was studied using an ascorbate-driven Fenton reaction (22) . Sealed glass tubes containing I mM FeC13, 1.5 mM H202, 13 mM dimethylsulfoxide (DMSO), and 1 mM ascorbate in 1 ml of Hanks' balanced salt solution (HBSS, without Ca2+ or Mg2', pH 7.0) were incubated for 30 min at 37°C in a shaking water bath. Production of -OH was assessed by generation of methane (CH4) from DMSO (23) . The concentration of CH4 in head space gas was measured with a gas chromatograph (Varian Associates, Inc., Palo Alto, CA; 6 ft X 2 mm stainless steel column packed with 60/80 Supelco Carbosieve B; flame ionization detector), using a CH4 standard.
In parallel experiments the ability of ibuprofen to attenuate H202 consumption by the Fenton reaction was studied in a system identical to that above, but without DMSO. After incubation for 30 min at 37°C, reaction mixtures were alkalinized to pH 1 I with 1 N NaOH and centrifuged at 3,000 g for 30 min to precipitate iron from solution. The concentration of H202 in supernatants was measured by the method of Thurman et al. (24) and compared to that of 1.5 mM H202 in HBSS also incubated at 37°C for 30 min.
IRON-MEDIATED LIPID PEROXIDATION
The ability of ibuprofen to suppress iron-mediated lipid peroxidation was studied using two methods. First, an iron-ascorbate system was used to oxidize arachidonic acid (25) . Sodium arachidonate (160 MM) was incubated with 150 uM FeC13 and 1 mM ascorbate in 3 ml of HBSS (pH 7.0) for 30 min at 370C in a shaking water bath. Peroxidation ofarachidonate was followed using the thiobarbituric acid assay of Buege and Aust (21), as described above.
Next, the ability of ibuprofen to inhibit spontaneous lipid peroxidation of brain homogenates was studied using a modification of the methods of Pacht and Davis (26) . Lipids of brain homogenates are known to undergo spontaneous autooxidation when exposed to air at 370C (27) . This peroxidation can be inhibited by iron chelators such as deferoxamine or transferrin but not by scavengers ofsuperoxide anion, H202, or * OH (26) . Guinea pig brain homogenates were prepared as previously described (26, 27) and frozen under N2 at -70'C until use. On the morning ofthe experiment, stock guinea pig brain homogenate was thawed, 0.5-ml aliquots were placed in borosilicate tubes and aliquots were diluted with 1.5 ml of phosphate buffered saline (PBS, pH 7.4) to a total volume of 2 ml. After vortexing, each tube was split into paired I-ml samples. One sample was stored under N2 at 40C. The remaining sample was incubated at 370C for 90 min. Both were then assayed for thiobarbituric acid reactive products as described above. The (Fig. 1 B) . We 4zed split block design (30) . Values for A W, wet/dry lung weight did not detect TXB2 in the recirculating lung perfusate in ei-,lavage and lung leak indexes for '25-HSA, and lung malondialther control or untreated phosgene lungs, and levels of 6-ketode were analyzed by one-way analysis of variance (30 (Fig. 1 A) . Ibuprofen, however, substantially decreased 0 Unexposed the elevated transvascular fluid flux seen after phosgene (Fig. 1 a Untreated B). Ibuprofen also significantly blocked formation of malona lbuprofen dialdehyde in phosgene-exposed lungs (Fig. 2) (Fig. 3, A and B) , but Ppa was similar in the two groups (14±1 mm Hg).
Effect of phosgene on transvascular flux of '25I-albumin. There was negligible transvascular flux of 1251 albumin in unexposed control lungs, as measured by lavage fluid or lung leak indexes (Fig. 4, A and B) . Phosgene exposure markedly increased both lavage and lung leak indexes. Pretreatment with ibuprofen significantly decreased movement of 1251I-albumin into lavage fluid and lung water after phosgene (Fig. 4) . In contrast, iron-treated ibuprofen failed to prevent the increase in albumin permeability caused by phosgene (Fig. 4) . Irontreated ibuprofen did not cause lung injury in a normal rabbit unexposed to phosgene (lavage leak index 0.017; lung leak index 0.040); nor did iron alone exacerbate phosgene lung injury (Fig. 4) . This suggests that the ability to bind iron is important to the mechanism by which ibuprofen protects against the lung injury caused by phosgene.
In vitro experiments Iron-mediated -OH generation. When combined with an appropriate reducing substance, iron is a potent catalyst for the generation of * OH from H202 (22) . As shown in Fig. 5, 1 mM FeCl3 in the presence of ascorbate catalyzed production of 1,012+12 ppm CH4 from 1.5 mM H202. As previously reported (29) , increasing the solubility of iron with EDTA enhanced CH4 production. Addition of 1 mM ibuprofen decreased CH4 generation by two-thirds, and 6 mM ibuprofen completely blocked CH4 generation. The reaction was also inhibited by the iron chelator deferoxamine 2 mM (1.4±0.3 ppm CH4, n = 5) and dimethylthiourea 15 Iron-mediated lipid peroxidation. It is well recognized that iron in the presence of a reducing substance will facilitate lipid peroxidation (32) . FeCl3 + ascorbate caused substantial peroxidation of arachidonic acid which was inhibited in a concentration-dependent manner by ibuprofen (Fig. 6) . Peroxida- ml, n = 10). The addition of 440 AM ibuprofen to brain homogenates inhibited malondialdehyde formation by over 80% (12±7 nmol/ml, n = 10).
Iron chelation studies. When transferrin binds Fe3+, its absorbance increases at 465 nm (A465) (28) . A chelator which enhances the solubility of iron greatly facilitates Fe3+ binding to transferrin (28). Table I shows that transferrin alone demonstrated little absorbance at 465 nm, and absorption remained relatively unchanged after the addition of FeCl3. However, when iron was solubilized by the chelator NTA, there was an increase in A465. This was also seen when ibuprofen was added with FeCl3, indicating that ibuprofen chelates iron.
Determination offree coordination sites in iron chelates. For catalytic activity, iron requires at least one coordination site that is open or occupied by a readily dissociable ligand such as water (29) . A chelate which contains a free coordination site and thus allows iron reactivity, such as Fe3+-EDTA, readily combines with azide at a free coordination site, causing a spectral shift. In contrast, a chelate with an compound that decreases iron reactivity, such as deferoxamine, leaves no coordination site open and shows no spectral shift when azide is added (29) . Sodium azide (NaN3) caused a concentration-dependent shift in the visible spectrum ofFe3+-EDTA, indicating the presence of a free coordination site at which transitional metal reactivity can occur (data not shown). In contrast, Fe3+-ibuprofen demonstrated a spectral shift with 1 M azide only at low ratios of ibuprofen to iron (Table II) . At higher ratios ( 12:1 ibuprofen to Fe3+) sufficient ibuprofen was present to bind all coordination sites, render iron nonreactive with azide, and prevent an azide-induced increase in absorbance (Table II) . Discussion Our objectives in this investigation were to establish a simple model of lung injury from inhaled toxic gas and determine if To accomplish this goal, we studied phosgene inhalation. Phosgene (COC12) is a colorless, heavier-than-air, oxidant gas with a lethal exposure dose (LC50) in humans of 500 ppm-min (50 ppm inhaled for 10 min) (9) . Phosgene is 10 times more toxic than chlorine (9) , and can react oxidatively at amine, hydroxyl, and thiol groups and with unsaturated carbon-carbon bonds to form a wide array of chemical modifications to biological molecules (33) .
The phosgene model we have developed closely reproduces the pathological findings and time sequence for development of phosgene lung injury in humans (9) . 4 h after exposure to 2,000 ppm-min, rabbit lungs were markedly congested and edematous. Lung malondialdehyde content was nearly doubled by phosgene exposure (Fig. 2) , suggesting that oxidant injury from phosgene initiates substantial peroxidation oflung lipids. Unlike oxidants, such as tert-butyl hydroperoxide (11) (12) (13) and hydrogen peroxide (34) , which stimulate lung production of thromboxane and cause pulmonary hypertension when administered into the vascular space, phosgene did not cause thromboxane generation and actually lowered Ppa in perfused lungs compared to unexposed controls. Nevertheless, phosgene caused a marked increase in lung A W (Figs. 1 B and 4 A) and W/D ratios (Fig. 3 B) . Phosgene also substantially altered the ability of lung microvessels to retain '25I albumin within the vascular compartment. Both lung and lavage fluid leak indexes were markedly increased by phosgene exposure (Fig. 4, A and B) . Taken as a whole, these results indicate that phosgene increases alveolar-capillary permeability, providing an experimental explanation for the clinical occurrence of noncardiogenic pulmonary edema in humans (9) .
Our study presents two major findings. First, ibuprofen markedly attenuates lung injury from phosgene. This is best illustrated in Fig. 1 B, in which ibuprofen significantly reduced the increase in transvascular fluid flux caused by phosgene, and in Fig. 4 , A and B, in which ibuprofen prevented the phosgene-induced increase in lung and lavage fluid leak indexes for '251-albumin. As shown in Fig. 3, A and B, this protective effect was present even when ibuprofen was given after phosgene exposure. Because ibuprofen did not decrease Ppa compared to untreated lungs, the protective effect is unlikely to be due to changes in vascular pressure. Nor can the protective effect of ibuprofen be attributed to inhibition of thromboxane synthesis, since phosgene exposure did not stimulate lung production of cyclooxygenase metabolites.
Second, our results may shed new light on how ibuprofen acts as an anti-inflammatory agent. The mechanism by which ibuprofen prevents oxidant lung injury from phosgene is suggested in Fig. 2 , which shows that ibuprofen markedly inhibits lipid peroxidation after phosgene. It is now well recognized that once initiated by membrane attack from a primary oxidant, continued lipid peroxidation requires the presence of iron (32) . Without iron or another transitional metal to facilitate electron transfer reactions, lipid peroxidation stops spontaneously (32) . Because iron chelators markedly inhibit lipid peroxidation (25, 26) , we hypothesized that ibuprofen might attenuate phosgene lung injury in part by chelating iron, and reasoned that treatment of ibuprofen with iron might eliminate its protective effect. As shown in Fig. 4 , iron-treated ibuprofen is ineffective.
Next, we sought to determine if ibuprofen could attenuate iron-mediated free radical reactions in vitro. Fig. 5 demonstrates that ibuprofen can prevent iron-mediated generation of * OH from H202. Our measurements of H202 consumption suggest that at lower concentrations relative to that of iron, ibuprofen probably acts as a -OH scavenger. At higher relative concentrations, ibuprofen may inhibit the Fenton reaction by acting as a chelator which renders iron nonreactive, so that H202 is not consumed. We also found that ibuprofen can attenuate iron-mediated peroxidation ofarachidonic acid (Fig.  6 ) and spontaneous lipid peroxidation in brain homogenates. To more clearly define whether ibuprofen can chelate iron, we took advantage ofthe observation that the rate ofFe3" binding to transferrin is greatly enhanced by compounds that chelate Fe3" and thus increase its solubility, and that binding ofFe3" to transferrin causes an increase in its absorbance at 465 nm (28). Table I shows that FeCl3 alone causes only a fraction of the increase in A465 that occurs when incubations are performed with transferrin in the presence of the chelators NTA or ibuprofen.
Finally, we sought to determine whether iron chelated with ibuprofen still has free coordination sites which might mediate electron transfer reactions. To test this we determined the effect of azide on the spectra produced by Fe3+-ibuprofen chelates. If a reactive coordination site exists in a chelate, azide will shift the spectra. If a reactive site does not exist, azide will not shift the spectra. Fe3+-EDTA chelates have a free coordination site and azide causes a progressive change in the visible spectrum of the chelate (data not shown). Fe3+-ibuprofen, however, undergoes a spectral shift with azide only at lower ratios of ibuprofen to iron (Table II) . When enough ibuprofen is present to occupy all available coordination sites, iron is rendered nonreactive and Fe3+-ibuprofen chelates demonstrate no increase in absorbance with azide (Table II) .
To our knowledge, this report presents the first evidence that ibuprofen may protect against injury in an intact biological system by interfering with iron-mediated reactions. The ability of ibuprofen to inhibit iron-mediated oxidation of arachidonic acid was first reported in 1979 by Peterson et al. (35) . These investigators suggested that ibuprofen inhibited in vitro lipid peroxidation by complexing with iron, and that formation of complexes with iron might underlie the activity of ibuprofen as a cyclooxygenase inhibitor. Later, Hiller et al. (36) reported that ibuprofen prevents * OH-mediated inactivation of a bacteriophage. More recently, Aruoma and Halliwell (37) showed that ibuprofen can scavenge * OH, and suggested that it can also chelate iron (37 (38) . Iron-chelating compounds have been previously demonstrated to have anti-inflammatory activity. Deferoxamine suppresses both acute and chronic experimental arthritis (39) and attenuates carrageenan-induced pleurisy (40) . The iron chelator 2,3-dihydroxybenzoic acid (41) and iron-binding protein apolactoferrin (42) prevent complement-and neutrophil-mediated acute lung injury in rats, and deferoxamine protects cultured pulmonary endothelium from the cytotoxicity caused by phorbol-activated neutrophils (43) . These studies suggest that iron chelating or site-directed -OH scavenging activity may contribute to ibuprofen's anti-inflammatory activity.
Ibuprofen has other effects which could partially explain its activity. Ibuprofen blocks neutrophil adherence in vitro (6, 44) and neutrophil aggregation and degranulation both in vitro and in vivo (45) . Ibuprofen has also been shown to attenuate neutrophil migration in vitro (6) and prevent migration of leukocytes into ischemic reperfused myocardium (46) . Whether these effects can be explained by iron chelation or site-directed scavenging of * OH is open to speculation. We did not see prominent influx of neutrophils into rabbit lungs immediately after phosgene. Currie et al. (47) , however, have observed neutrophil influx into rat lungs 24 h after exposure to phosgene, and it is therefore conceivable that ibuprofen may also protect from phosgene in part by preventing leukocyte influx into lungs or by scavenging leukocyte-derived -OH.
Our results have several important implications. First, should studies with other toxic gases confirm our findings in phosgene-exposed rabbits, ibuprofen might become a life-saving therapy for victims of toxic gas inhalation. Second, a number of studies demonstrate that the protective effects of ibuprofen on lung injury cannot be explained by cyclooxygenase inhibition (6, 48, 49) . Our results suggest that in addition to inhibiting cyclooxygenase, ibuprofen may attenuate lung injury by preventing iron-mediated generation of oxidants and lipid peroxidation. Finally, our findings may shed light on the mechanism by which ibuprofen protects from septic lung injury. Brigham et al. (50) have recently shown that reactive oxygen species mediate the direct toxicity of endotoxin for cultured pulmonary artery endothelium. Also, a major mediator of the effects of endotoxin is tumor necrosis factor (51, 52), which has recently been shown to dramatically increase * OH production within cells (53). Because ibuprofen prevents the hypotension and organ injury caused by tumor necrosis factor infusion (54), ibuprofen might protect against septic lung injury in part by scavenging or inhibiting the iron-dependent generation of reactive oxygen species produced in response to endotoxin or cytokines.
